# Who Can Take a GLP-1 for Weight Loss?

Learn the usual starting criteria for GLP-1 weight-management treatment and what a clinician needs to review before prescribing.

Canonical HTML: [Who Can Take a GLP-1 for Weight Loss?](https://joinelovi.com/blog/who-can-take-glp-1)

Prepared by [Ēlovi Editorial](https://joinelovi.com/blog/authors/elovi-editorial).
Published: 2026-09-18T22:00:28.999Z. Updated: 2026-09-18T22:00:28.999Z.
Prepared by Ēlovi Editorial with AI assistance. Sources checked: 2026-09-18. Reviewed by the Ēlovi editorial team, which includes licensed clinicians.
[Editorial process](https://joinelovi.com/blog/editorial-policy).

## The short answer

For adult weight management, clinicians commonly consider medication at a BMI of 30 or higher, or 27 or higher with a weight-related health condition. Those criteria start the assessment; your medical history, other medicines, and the specific product determine whether treatment is appropriate.

## What are the usual starting criteria?

For adults seeking weight-management medication, a common threshold is BMI of at least 30, or at least 27 with a weight-related condition such as high blood pressure or type 2 diabetes. A clinician must still assess whether treatment makes sense for the individual. [1](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)

This article focuses on adult weight management. Different conditions and products have their own prescribing criteria. If you are new to the terminology, our [GLP-1 guide](https://joinelovi.com/blog/glp-1-guide) explains the basics.

Do not change a measurement or leave out information to fit an online form. A useful assessment begins with an accurate picture, including anything you are unsure about.

## Three questions that are often mixed together

| Question | What it means | Who can answer it? |
| --- | --- | --- |
| Is treatment medically appropriate? | Whether the expected benefits and risks make sense for you | The prescribing clinician |
| Will my plan pay for it? | Whether your insurance benefits and requirements cover the proposed product | Your insurer, with information from your clinician |
| Can this provider treat me? | Whether the service can provide the care you need where you live | The provider |

Ask each separately. A payment quote does not explain medical suitability. Likewise, a clinical recommendation does not tell you what your insurer will pay. Write the answers in separate places so you can compare them later.

## What history should you share?

Tell the clinician about previous pancreatitis, gallbladder or kidney problems, diabetic eye disease, and significant stomach or digestive problems. Mention recent vomiting, diarrhea, or difficulty drinking. Semaglutide’s patient information specifically highlights these matters for discussion. [2](https://medlineplus.gov/druginfo/meds/a618008.html)

Also disclose thyroid cancer in yourself or your family, MEN2, and previous allergic reactions to medicines. These are important safety questions for tirzepatide. If a relative had “thyroid cancer” but you do not know the type, ask the clinician what records would help. [3](https://medlineplus.gov/druginfo/meds/a622044.html)

These examples are not a complete medical screen. You do not need to decide by yourself which diagnoses matter. Bring the whole history and let the clinician ask follow-up questions.

For each past problem, note roughly when it happened, whether it is ongoing, and who treated it. A sentence such as “I had gallbladder surgery in 2021; I can request the record” is more useful than a checked box without context.

## Bring a usable medication list

You can take photos of labels or make a list. Include prescriptions, nonprescription medicines, vitamins, supplements, and anything obtained through another online service. Patient information for tirzepatide asks you to share these products with both the prescriber and pharmacist. [3](https://medlineplus.gov/druginfo/meds/a622044.html)

Use this format:

| Item | What to record |
| --- | --- |
| Name | Copy the label rather than describing the pill’s color |
| Directions | Write what you actually take and how often |
| Purpose | Why you take it, if you know |
| Prescriber | The office that manages it |
| Recent change | Any recent start, stop, or adjustment |
| Question | Anything you want the clinician to check |

If you already use a weight-loss medication, bring its label and the date you last took it. Request explicit instructions about any proposed change. Do not assume a new prescription means you should combine it with your existing supply.

## Pregnancy and future plans belong in the discussion

Tell the clinician if you are pregnant, breastfeeding, or planning pregnancy. Semaglutide injection information advises stopping at least two months before a planned pregnancy under your clinician’s direction. [2](https://medlineplus.gov/druginfo/meds/a618008.html)

You can raise the subject even if your plans are uncertain. Ask: “If my plans change, who should I contact, and what would we do?” If you use oral contraception and are considering tirzepatide, read the specific precaution in our [semaglutide versus tirzepatide comparison](https://joinelovi.com/blog/semaglutide-vs-tirzepatide) and discuss it before starting.

## Prepare a short appointment note

Use these prompts to make the conversation more productive:

1. **My main concern is:** Describe what has led you to seek help now.
2. **My weight history is:** Include major changes and their timing.
3. **What I have tried:** Record what helped, what did not, and what was hard to continue.
4. **My health history includes:** Bring diagnoses and records you can access.
5. **My current medicines are:** Attach the list or label photos.
6. **My practical constraints are:** Mention cost, work schedule, caregiving, or difficulty attending follow-ups.
7. **Before deciding, I need to understand:** Choose the questions most important to you.

This is a preparation tool, not a scoring system. You should not have to earn a particular answer by describing enough failed attempts or dissatisfaction with your body.

## What if a GLP-1 is not recommended?

Ask the clinician to explain the reason and the next reasonable step. Is more information needed? Is another approach more appropriate? Would a different setting offer care that this provider cannot deliver?

Get the explanation in language you can use. “Please explain what would need to be clarified before reconsidering medication” is a fair question. You can also ask how to obtain a copy of your assessment for your usual clinician.

## Common questions

### Can an online calculator tell me if I qualify?

A calculator can provide a number from the measurements you enter. It cannot review your history, evaluate symptoms, or choose a prescription. Use it to prepare for a conversation, not to replace one.

### Is an online assessment enough?

Ask what the provider reviews, how follow-up questions are handled, and when they would request records, testing, or an in-person visit. Our [online-provider checklist](https://joinelovi.com/blog/how-to-choose-online-glp-1-provider) helps you compare the process.

### Does a compounded option change the assessment?

You still need a clinical assessment and an explanation of the exact proposed preparation. Our [compounded versus brand-name guide](https://joinelovi.com/blog/compounded-vs-brand-name-glp-1) covers the additional questions to ask before accepting that recommendation.

## References

1. [Prescription Medications to Treat Overweight & Obesity](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity) — National Institute of Diabetes and Digestive and Kidney Diseases
2. [Semaglutide Injection](https://medlineplus.gov/druginfo/meds/a618008.html) — MedlinePlus
3. [Tirzepatide injection](https://medlineplus.gov/druginfo/meds/a622044.html) — MedlinePlus

For general education; this does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.